Latest Breaking News On - Airway centre - Page 2 : comparemela.com

Dexterra Group Inc : Dexterra Announces Date for Q1 Results and Updated Annual Shareholder Meeting Date

Dexterra Group Inc : Dexterra Announces Date for Q1 Results and Updated Annual Shareholder Meeting Date
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlDenise achonuAirway centreDexterra group incNewsfile corpAnnual meetingFloor mississaugaDexterra groupAktien sie

Dexterra Announces Date for Q1 Results and Updated Annual Shareholder Meeting Date

Dexterra Group Inc. announces that it intends to release its Q1 2024 results on May 14, 2024 after market close and has scheduled a conference call and webcast to begin promptly at 8:30 a.m. Eastern.

Denise achonuDexterra group incAirway centreNewsfile corpAnnual meetingFloor mississauga

Dexterra Announces Date of Q4 2023 Results and Conference Call

Dexterra Announces Date of Q4 2023 Results and Conference Call
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Denise achonuNewsfile corpAirway centreDexterra group incChief financialFloor mississauga

Dexterra Group Inc : Dexterra Announces Date of Q4 2023 Results and Conference Call

Dexterra Group Inc : Dexterra Announces Date of Q4 2023 Results and Conference Call
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Denise achonuDexterra group incNewsfile corpAirway centreChief financialFloor mississaugaDexterra group

Takeda Enters Into Two-Year Contract with Canadian Blood Services for GLASSIA®, Treatment for Rare form of Emphysema - Takeda Pharmaceutical (NYSE:TAK)

Availability of GLASSIA® represents significant milestone for patients with emphysema due to severe hereditary deficiency of Alpha-1 antitrypsin TORONTO, Dec. 20, 2023 /CNW/ - Takeda Canada Inc. (Takeda) has

Angela dianoKen chapmanCanadian blood servicesHealth canadaTakeda pharmaceutical company limitedTakeda canada incUniversity health networkUniversity of torontoAsthma airway centreTakeda canadaRelated productsAirway centreExecutive directorProteinase inhibitorRute fernandesGeneral manager